Cargando…
Chidamide Inhibits Acute Myeloid Leukemia Cell Proliferation by lncRNA VPS9D1-AS1 Downregulation via MEK/ERK Signaling Pathway
Irregular histone modification and aberrant lncRNAs expression are closely related to the occurrence of tumors including acute myeloid leukemia (AML). However, the effects and specific underlying molecular mechanism of histone deacetylase inhibitors on lncRNA expression in AML cells are unclear. Her...
Autores principales: | Lin, Liman, Que, Yimei, Lu, Pingfan, Li, Huimin, Xiao, Min, Zhu, Xiaojian, Li, Dengju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604502/ https://www.ncbi.nlm.nih.gov/pubmed/33192510 http://dx.doi.org/10.3389/fphar.2020.569651 |
Ejemplares similares
-
Trends in disease burden of chronic myeloid leukemia at the global, regional, and national levels: a population-based epidemiologic study
por: Ning, Liqing, et al.
Publicado: (2020) -
Study on the Immune Escape Mechanism of Acute Myeloid Leukemia With DNMT3A Mutation
por: Que, Yimei, et al.
Publicado: (2021) -
LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway
por: Liu, Jian, et al.
Publicado: (2020) -
LncRNA GAS8‐AS1 downregulates lncRNA NEAT1 to inhibit glioblastoma cell proliferation
por: Wu, Xiaoming, et al.
Publicado: (2021) -
LncRNA ENST869 Targeting Nestin Transcriptional Region to Affect the Pharmacological Effects of Chidamide in Breast Cancer Cells
por: Feng, Xiuyan, et al.
Publicado: (2022)